ongoing

The REVIVAL pilot trial asks the question: Is it feasible to conduct a large randomized controlled trial (RCT) evaluating the efficacy and safety of the Ross procedure compared to conventional aortic valve replacement (AVR)? Specifically, can participating centres recruit an average of six patients per year using the expertise-based RCT protocol we have developed with acceptable compliance to allocation?

REVIVAL Presentation - Download PDF
Study Type

Interventional - Procedure

Study Design

An international multicenter randomized trial

NO. of Countries

2

NO. of Sites

5

NO. of Participants

60

Study Period

2019-2020

Sponsor

PHRI

Canadian Institutes of Health Research (CIHR)

McMaster Surgical Associates (MSA)

Back To Top